Zobrazeno 1 - 10
of 69
pro vyhledávání: ''
Publikováno v:
JAMA Surgery. 157:79
Autor:
Patrick Lewicki, Spyridon P. Basourakos, Jonathan E. Shoag, Douglas S. Scherr, Camilo Arenas-Gallo, Yuqing Qiu, Lee Ponsky
Publikováno v:
JAMA Surg
This study estimates the real-world surgical practice response to a randomized clinical trial on mannitol use during partial nephrectomy.
Autor:
Timothy M. Pawlik, Paul J. Karanicolas, Matthew H.G. Katz, Dimitrios Moris, Michail N Mavros, Eileen M. O'Reilly
Publikováno v:
Hepatobiliary Surg Nutr
Importance Adjuvant chemotherapy is the standard of care for resected pancreatic ductal adenocarcinoma (PDAC) based on level 1 evidence, but some studies suggest that a neoadjuvant approach (which is standard for borderline resectable PDAC) may be pr
Publikováno v:
JAMA Surgery. 156:688
Autor:
Suma Choorapoikayil, Kai Zacharowski, Isabel Taeuber, Eva Herrmann, Patrick Meybohm, Leila Messroghli, Stephanie Weibel, Peter Kranke, Vanessa Neef, Tobias Schlesinger
Publikováno v:
JAMA Surg
Importance Tranexamic acid (TXA) is an efficient antifibrinolytic agent; however, concerns remain about the potential adverse effects, particularly vascular occlusive events, that may be associated with its use. Objective To examine the association b
Publikováno v:
The Pancreas: An Integrated Textbook of Basic Science, Medicine, and Surgery, Second Edition
There is increasing interest in the use of adjuvant treatment for pancreatic cancer since although postoperative mortality is much improved, median long-term survival is only on the order of 11–15 mo. Despite a proliferation of studies in advanced
Autor:
Pompiliu Piso, Wim Ceelen, Ignace H. J. T. de Hingh, Diane Goéré, François Quenet, P. Barrios, Olivier Glehen, Armando Sardi, Marcello Deraco, B. J. Moran, Dario Baratti, Kurt Van der Speeten, Yutaka Yonemura, David L. Morris, Edward A. Levine, Shigeki Kusamura, Joerg O.W. Pelz, Francesco Barretta, A. Gomez-Portilla, Paul H. Sugarbaker, Eran Nizri, Santiago González-Moreno, Laurent Villeneuve
Publikováno v:
JAMA Surgery. 156:e206363
Studies on the prognostic role of hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei (PMP) are currently not available.To evaluate outcomes after cytoreductive surgery (CRS) and HIPEC compared with CRS alone in patients with
Publikováno v:
JAMA Surg
IMPORTANCE: Adults with comorbidity have less physiological reserve and an increased rate of postoperative mortality and readmission after the stress of a major surgical intervention. OBJECTIVE: To assess postoperative mortality and readmission among
Publikováno v:
JAMA Surgery. 155:1171